“…The presence of MIAC is associated with increased risk of adverse perinatal outcomes, such as early preterm birth[164, 165, 171, 177, 202, 207], neonatal sepsis[104, 167], bronchopulmonary dysplasia[48, 206], neonatal white matter brain lesions[203, 210], and cerebral palsy[13, 14, 176, 205, 209]. Although MIAC is considered to be confined to the amniotic cavity and not a systemic condition, studies with flow cytometry have shown phenotypic and metabolic changes in leukocytes[45, 46] as well as changes in maternal cytokines concentration [22, 24, 34, 41, 62, 63, 68, 125, 126, 141, 143, 198]. These observations suggest that biomarkers for MIAC may be found in the maternal circulation.…”